2m 2m 2m 2m 2m 2m 2m
Opus Genetics (IRD)
NASDAQ
$3.84+$0.03 (+0.89%)
Price as of Jul 14, 2026 8:30 AM EDT- $314.6MMarket Cap
- 243.24%1-Year Change
- BiotechnologyIndustry
Opus Genetics (IRD)
$3.84+$0.03 (+0.89%)
IRD | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.81 | ||
Change | -$0.11 (-2.81%) | ||
Open | $3.90 | ||
High | $3.91 | ||
Low | $3.76 | ||
Previous Close | $3.92 | ||
Volume | 895,050 | ||
30-Day Average Volume | 1,222,920 | ||
1-Week Change | -6.39% | ||
1-Month Change | -5.69% | ||
1-Year Change | 243.24% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 82.6M | ||
Total Assets | $66.8M | ||
Market Cap | $314.6M | ||
Enterprise Value | $255.8M | ||
Period: QTR TTM FY | |||
Revenue | $2.2M | ||
Net Income | -$65.5M | ||
Free Cash Flow | -$12.7M | ||
EBIT | -$65.4M | ||
EBITDA | -$65.4M | ||
Net Working Capital | $57.3M | ||
EPS | -$0.75 | ||
Enterprise Value/EBITDA | -4 | ||
Enterprise Value/Revenue | 119 | ||
P/B | -7 | ||
P/E | -5 | ||
PEG | 0 | ||
Price/Free Cash Flow | -25 | ||
Price/Operating Cash Flow | -25 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue